Asberg M - Search Results

1

Effects of antidepressant treatments on platelet tritiated imipramine binding in major depressive disorder.

Wägner A, Aberg-Wistedt A, Asberg M, Bertilsson L, Mårtensson B, Montero D. Wägner A, et al. Among authors: asberg m. Arch Gen Psychiatry. 1987 Oct;44(10):870-7. doi: 10.1001/archpsyc.1987.01800220032006. Arch Gen Psychiatry. 1987. PMID: 2821953 Clinical Trial.

2

Serotonin selective antidepressant drugs: past, present, future.

Asberg M, Mårtensson B. Asberg M, et al. Clin Neuropharmacol. 1993;16 Suppl 3:S32-44. Clin Neuropharmacol. 1993. PMID: 8131153 Review.

3

Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder.

Mårtensson B, Wägner A, Beck O, Brodin K, Montero D, Asberg M. Mårtensson B, et al. Among authors: asberg m. Acta Psychiatr Scand. 1991 Feb;83(2):125-33. doi: 10.1111/j.1600-0447.1991.tb07377.x. Acta Psychiatr Scand. 1991. PMID: 1708190

4

Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder.

Wgner A, Montero D, Mårtensson B, Siwers B, Asberg M. Wgner A, et al. Among authors: asberg m. J Affect Disord. 1990 Oct;20(2):101-13. doi: 10.1016/0165-0327(90)90123-p. J Affect Disord. 1990. PMID: 2176228

5

Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression.

Murray V, von Arbin M, Bartfai A, Berggren AL, Landtblom AM, Lundmark J, Näsman P, Olsson JE, Samuelsson M, Terént A, Varelius R, Asberg M, Mårtensson B. Murray V, et al. Among authors: asberg m. J Clin Psychiatry. 2005 Jun;66(6):708-16. doi: 10.4088/jcp.v66n0606. J Clin Psychiatry. 2005. PMID: 15960563 Clinical Trial.

6

Therapeutic effects of serotonin uptake inhibitors in depression.

Asberg M, Eriksson B, Mårtensson B, Träskman-Bendz L, Wägner A. Asberg M, et al. J Clin Psychiatry. 1986 Apr;47 Suppl:23-35. J Clin Psychiatry. 1986. PMID: 2937776 Review.

7

Lower 3H-imipramine binding in platelets from untreated depressed patients compared to healthy controls.

Wägner A, Aberg-Wistedt A, Asberg M, Ekqvist B, Mårtensson B, Montero D. Wägner A, et al. Among authors: asberg m. Psychiatry Res. 1985 Oct;16(2):131-9. doi: 10.1016/0165-1781(85)90006-x. Psychiatry Res. 1985. PMID: 3865253

8

CSF 5-HIAA predicts suicide risk after attempted suicide.

Nordström P, Samuelsson M, Asberg M, Träskman-Bendz L, Aberg-Wistedt A, Nordin C, Bertilsson L. Nordström P, et al. Among authors: asberg m. Suicide Life Threat Behav. 1994 Spring;24(1):1-9. Suicide Life Threat Behav. 1994. PMID: 7515519

9

Memory effects of clomipramine treatment: relationship to CSF monoamine metabolites and drug concentrations in plasma.

Bartfai A, Asberg M, Mårtensson B, Gustavsson P. Bartfai A, et al. Among authors: asberg m. Biol Psychiatry. 1991 Dec 1;30(11):1075-92. doi: 10.1016/0006-3223(91)90179-p. Biol Psychiatry. 1991. PMID: 1723300

10

Biochemical effects of antidepressant treatment--studies of monoamine metabolites in cerebrospinal fluid and platelet [3H]imipramine binding.

Asberg M, Wägner A. Asberg M, et al. Ciba Found Symp. 1986;123:57-83. doi: 10.1002/9780470513361.ch5. Ciba Found Symp. 1986. PMID: 2434288 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters